Outlook Therapeutics, Inc. Proceeds from Notes Payable
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2018-12-18
- Outlook Therapeutics, Inc. proceeds from notes payable for the quarter ending 2017-09-30 was $0.00.
- Outlook Therapeutics, Inc. proceeds from notes payable for the quarter ending 2017-06-30 was $5.00M.
- Outlook Therapeutics, Inc. proceeds from notes payable for the quarter ending 2017-03-31 was $1.65M.
- Outlook Therapeutics, Inc. proceeds from notes payable for the quarter ending 2016-12-31 was $8.35M.
- Outlook Therapeutics, Inc. proceeds from notes payable for fiscal 2017 was $15.00M.
- Outlook Therapeutics, Inc. proceeds from notes payable for fiscal 2015 was $10.88M.
| Period end | Proceeds from Notes Payable 1 month | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | $5.00M derived: sum of 2 quarters · filed 2018-12-18 | $6.65M derived: sum of 3 quarters · filed 2018-12-18 | $15.00M 10-K · filed 2018-12-18 | |
| 2017-06-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $6.65M derived: sum of 2 quarters · filed 2018-08-14 | $15.00M 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $10.00M 10-Q · filed 2018-05-15 | |||
| 2017-01-31 | $1.65M 10-Q · filed 2017-05-15 | ||||
| 2016-12-31 | $8.35M 10-Q · filed 2018-02-14 | ||||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | $2.50M derived: sum of 2 quarters · filed 2016-12-29 | $10.88M 10-K · filed 2016-12-29 | ||
| 2015-06-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $10.88M 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | $8.38M 10-Q · filed 2016-06-27 |